REG - Thruvision Group PLC - Sharesave option grant to Executive Director

ThruvisionAnnouncement

13/12/2024 12:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241213:nRSM0783Qa&default-theme=true

RNS Number : 0783Q  Thruvision Group PLC  13 December 2024

13 December 2024

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Sharesave option grant to Executive Director

 

 

Thruvision Group plc (AIM: THRU), ("Thruvision") the leading provider of
walk-through security technology, announces a grant of share options under the
Thruvision Sharesave Scheme (the "Scheme").

 

The Remuneration Committee of the Group have granted, under the rules of the
Scheme, an option over 194,595 Ordinary 1p shares with an exercise price of
7.4 pence per share to Victoria Balchin.

 

The exercise price, set on 21 November 2024, is calculated on the basis of 80%
of the closing middle market price of Thruvision shares on 21 November 2024.
The option may be exercised between 1 March 2028 and 31 August 2028, assuming
the conditions of the Scheme are met.

 

The notifications below, made in accordance with the requirements of the EU
Market Abuse Regulation, provides further detail:

 

 1.   Details of the person discharging managerial responsibilities/person closely
      associated
 (a)  Name                                             Victoria Balchin
 2.   Reason for the notification
 (a)  Position/status                                  Chief Financial Officer
 (b)  Initial notification/ Amendment                  Initial notification
 3.   Details of the issuer
 (a)  Name                                             Thruvision Group plc
 (b)  LEI                                              213800IZG9GM6G2TZE04
 4.   Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 (a)  Description of the Financial Instrument          Ordinary shares of £0.01 each
 (b)  Identification code of the Financial Instrument  GB00B627R876
 (c)  Nature of the transaction                        Grant of Options under the Sharesave Scheme.

 (d)  Price(s) and volume(s)                           Price(s)                    Volume(s)
                                                       7.4                         194,595

 (e)  Aggregated information                           N/A

      -              Aggregated volume

      -              Price
 (f)  Date of the transaction                          13 December 2024
 (g)  Place of the transaction                         Not a trading venue

 

 

For further information please contact:

 

Thruvision Group
plc
+44 (0)1235 425400

Tom Black, Executive Chairman

Victoria Balchin, Chief Financial Officer

 

Investec Investment Banking (NOMAD & Broker)                  +44
(0)20 7597 5970

Patrick Robb / James Rudd

 

About Thruvision (www.thruvision.com)

 

Thruvision is the leading developer, manufacturer and supplier of walk-through
security technology. Its technology is deployed in more than 20 countries
around the world by government and commercial organisations in a wide range of
security situations, where large numbers of people need to be screened
quickly, safely and efficiently. Thruvision's patented technology is uniquely
capable of detecting concealed objects in real time using an advanced AI-based
detection algorithm. The Group's offices are near Oxford and Washington DC

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCLXLFFZLLXFBE